BREAKING

RPM International Inc. (RPM) Posts Q3 2026 Results 1 minute ago Delta Air Lines (DAL) Q1 2026 Earnings: Key financials and quarterly highlights 41 minutes ago Academy Sports and Outdoors Drops 6.0% Amid Sector-Wide Selling 21 hours ago Rh Shares Dropping 5.9% 22 hours ago UnitedHealth Group Incorporated Shares Jumping 8.1% 22 hours ago Synergy CHC Corp. (SNYR) Q4 Earnings: Misses on EPS, Revenue Recap 6 days ago Lindsay Corporation Q2: Revenue Slips to $157.7M 6 days ago Kaiser Aluminum Corporation (KALU) Jumps 7.1% to $129.05 6 days ago Sterling Infrastructure, Inc. (STRL) Jumps 5.9% to $431.23 6 days ago Penguin Solutions Q2 Fiscal 2026 Financial Review 6 days ago RPM International Inc. (RPM) Posts Q3 2026 Results 1 minute ago Delta Air Lines (DAL) Q1 2026 Earnings: Key financials and quarterly highlights 41 minutes ago Academy Sports and Outdoors Drops 6.0% Amid Sector-Wide Selling 21 hours ago Rh Shares Dropping 5.9% 22 hours ago UnitedHealth Group Incorporated Shares Jumping 8.1% 22 hours ago Synergy CHC Corp. (SNYR) Q4 Earnings: Misses on EPS, Revenue Recap 6 days ago Lindsay Corporation Q2: Revenue Slips to $157.7M 6 days ago Kaiser Aluminum Corporation (KALU) Jumps 7.1% to $129.05 6 days ago Sterling Infrastructure, Inc. (STRL) Jumps 5.9% to $431.23 6 days ago Penguin Solutions Q2 Fiscal 2026 Financial Review 6 days ago

ADVERTISEMENT

Breaking News

Unicycive Therapeutics, Inc. (UNCY) Reports FY2025 Earnings

Unicycive Therapeutics, Inc. (UNCY) posted Q4 2025 basic and diluted EPS of -$1.67.

March 30, 2026 1 min read

Unicycive Therapeutics, Inc. (UNCY) posted Q4 2025 basic and diluted EPS of -$1.67.

UNCY

UNCY|EPS -$1.67|Net Loss $26.6M

Unicycive Therapeutics, Inc. (UNCY) posted FY 2025 basic and diluted EPS of -$1.67.

Unicycive Therapeutics, Inc. is a Biotechnology company. Bottom line showed a net loss of $26.6M.

Wall Street consensus stands at 10 buy, 1 hold, 0 sell.

This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.

ADVERTISEMENT

Tags: #earnings #Inc. #UNCY #Unicycive Therapeutics